Pages that link to "Q47655490"

The following pages link to Win 55212-2, a cannabinoid receptor agonist, attenuates leukocyte/endothelial interactions in an experimental autoimmune encephalomyelitis model (Q47655490):

Displaying 48 items.

• The endocannabinoid system as an emerging target of pharmacotherapy (Q24648473) (← links)
• Modulation of cannabinoid receptor activation as a neuroprotective strategy for EAE and stroke (Q33793559) (← links)
• In vitro and in vivo characterization of the new analgesic combination Beta-caryophyllene and docosahexaenoic Acid. (Q33944886) (← links)
• Unraveling the complexities of cannabinoid receptor 2 (CB2) immune regulation in health and disease (Q34188446) (← links)
• A synthetic cannabinoid agonist promotes oligodendrogliogenesis during viral encephalitis in rats (Q34308648) (← links)
• Cannabinoid control of neuroinflammation related to multiple sclerosis (Q34583231) (← links)
• Identification of the synthetic cannabinoid R(+)WIN55,212-2 as a novel regulator of IFN regulatory factor 3 activation and IFN-beta expression: relevance to therapeutic effects in models of multiple sclerosis (Q34695691) (← links)
• CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways (Q34733645) (← links)
• Cannabidiol: a promising drug for neurodegenerative disorders? (Q34948216) (← links)
• Anandamide inhibits Theiler's virus induced VCAM-1 in brain endothelial cells and reduces leukocyte transmigration in a model of blood brain barrier by activation of CB(1) receptors (Q35213727) (← links)
• Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). (Q35589934) (← links)
• Differential migratory properties of monocytes isolated from human subjects naïve and non-naïve to Cannabis (Q35766665) (← links)
• Cannabinoid 2 receptor activation reduces leukocyte adhesion and improves capillary perfusion in the iridial microvasculature during systemic inflammation. (Q35789673) (← links)
• CB2 receptor activation attenuates microcirculatory dysfunction during cerebral ischemic/reperfusion injury. (Q35870490) (← links)
• Update on the role of cannabinoid receptors after ischemic stroke (Q35915645) (← links)
• A CB2-Selective Cannabinoid Suppresses T-Cell Activities and Increases Tregs and IL-10 (Q35927832) (← links)
• Cannabinoid-based drugs as anti-inflammatory therapeutics (Q36111923) (← links)
• Targeting cannabinoid receptor CB(2) in cardiovascular disorders: promises and controversies (Q36346915) (← links)
• Signaling through cannabinoid receptor 2 suppresses murine dendritic cell migration by inhibiting matrix metalloproteinase 9 expression (Q36370835) (← links)
• Biology and therapeutic potential of cannabinoid CB2 receptor inverse agonists (Q36416335) (← links)
• Direct suppression of autoreactive lymphocytes in the central nervous system via the CB2 receptor (Q36416340) (← links)
• Cannabinoid receptors in acute and chronic complications of atherosclerosis. (Q36416368) (← links)
• Targeting the CB2 receptor for immune modulation (Q36596663) (← links)
• Cannabinoid receptor 2 suppresses leukocyte inflammatory migration by modulating the JNK/c-Jun/Alox5 pathway (Q36832642) (← links)
• Molecular targets for disrupting leukocyte trafficking during multiple sclerosis (Q36885184) (← links)
• Modulation of the balance between cannabinoid CB(1) and CB(2) receptor activation during cerebral ischemic/reperfusion injury (Q36961126) (← links)
• Cannabinoid CB(2) receptor activation decreases cerebral infarction in a mouse focal ischemia/reperfusion model (Q37087780) (← links)
• G protein-coupled receptors as therapeutic targets for multiple sclerosis (Q37112554) (← links)
• Emerging strategies for exploiting cannabinoid receptor agonists as medicines (Q37230665) (← links)
• Cannabinoids as therapeutic agents for ablating neuroinflammatory disease (Q37264965) (← links)
• Cannabinoids inhibit T-cells via cannabinoid receptor 2 in an in vitro assay for graft rejection, the mixed lymphocyte reaction (Q37396781) (← links)
• Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS (Q37531460) (← links)
• Neuroprotective agents: Cannabinoids (Q37855122) (← links)
• Label-Free Screening Assays: A Strategy for Finding Better Drug Candidates (Q37856304) (← links)
• Cannabinoid as a neuroprotective strategy in perinatal hypoxic-ischemic injury (Q37905540) (← links)
• The endocannabinoid system: a revolving plate in neuro-immune interaction in health and disease (Q37988405) (← links)
• Functions of the CB1 and CB 2 receptors in neuroprotection at the level of the blood-brain barrier (Q38220272) (← links)
• Using the endocannabinoid system as a neuroprotective strategy in perinatal hypoxic-ischemic brain injury (Q38248001) (← links)
• The synthetic cannabinoid R(+)WIN 55,212-2 inhibits the interleukin-1 signaling pathway in human astrocytes in a cannabinoid receptor-independent manner (Q40384271) (← links)
• Tapping into the endocannabinoid system to ameliorate acute inflammatory flares and associated pain in mouse knee joints (Q41983974) (← links)
• Cannabinoid receptor 2 activation reduces intestinal leukocyte recruitment and systemic inflammatory mediator release in acute experimental sepsis (Q42110787) (← links)
• Targeting CB2 receptor as a neuroinflammatory modulator in experimental autoimmune encephalomyelitis (Q48822688) (← links)
• Immunoregulation of experimental autoimmune encephalomyelitis by the selective CB1 receptor antagonist (Q48895143) (← links)
• Cannabinoid Actions on Neural Stem Cells: Implications for Pathophysiology (Q64073287) (← links)
• Cannabinoids and multiple sclerosis (Q81478365) (← links)
• Cannabinoid Receptor and N‐acyl Phosphatidylethanolamine Phospholipase D—Evidence for Altered Expression in Multiple Sclerosis (Q83248279) (← links)
• WIN55212-2 ameliorates atherosclerosis associated with suppression of pro-inflammatory responses in ApoE-knockout mice (Q85089270) (← links)
• Perspectives on Cannabis-Based Therapy of Multiple Sclerosis: A Mini-Review (Q90092927) (← links)